Product Information
HALOPERIDOL DEC 500 MG/5 ML VL is a generic product labeled by BluePoint Laboratories, priced at $15.5981 per ML under NDC 68001065941. Its NADAC has been published 49 times since Oct 29, 2025.
FDA first approved this application on Oct 22, 2019. Its Orange Book therapeutic-equivalence code is AO.
Strength
500 mg/5mL
Manufacturer
BluePoint LaboratoriesNDC
68001065941
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA211180FDA Approved
10/22/2019
TE Code
AO
On Market Since
6/12/2025
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has been published 49 times since Oct 29, 2025, and over the history we have for it it has risen 13.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.5981 per ML |
|---|---|
| All-time high | $15.5981 (Sep 30, 2026) |
| All-time low | $12.9792 (Jul 22, 2026) |
| 52-week high | $15.5981 |
| 52-week low | $12.9792 |
| Median price | $13.6419 |
| Average price | $13.7282 |
| Largest weekly change | +10.4% (Aug 19, 2026) |
| Weeks tracked | 49 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Haloperidol decanoate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 500 MG/5 ML VL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 500 MG/5 ML VL, manufactured by BluePoint Laboratories, is $15.5981 per ML (NDC 68001065941), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 500 MG/5 ML VL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has risen 13.9%. It has been tracked across 49 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 500 MG/5 ML VL?
Since Oct 29, 2025, the NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has ranged from a low of $12.9792 (Jul 22, 2026) to a high of $15.5981 (Sep 30, 2026), with a median of $13.6419 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 500 MG/5 ML VL?
No other NADAC-published product currently shares the active ingredient and strength of HALOPERIDOL DEC 500 MG/5 ML VL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HALOPERIDOL DEC 500 MG/5 ML VL?
HALOPERIDOL DEC 500 MG/5 ML VL (NDC 68001065941) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.